Wednesday, January 9, 2008

MMI, Steel Partners Ratchet up Effort at Brinks

A tag team of two investors is seeking to unlock the value and vault of armored car transport company Brinks Co.

Backing the proxy contest efforts of another activist investor, Steel Partners II LP’s Warren Lichtenstein delivered a letter to Brinks board urging it to complete a tax-free spin off one of its two business segments, according to a Wednesday government filing.

Lichtenstein’s endeavor follows up on a proxy contest launched by activist Clay Lifflander to put four candidates on the Richmond, Va.-based company’s board in November. Lifflander, portfolio manager of MMI Investments LP of New York, reported owning an 8.4% stake while Steel Partners reported Dec. 31 that it owned a 6.2% of Brinks.

In the letter, Lichtenstein said Steel Partners is encouraged by Brinks recent retention of Monitor Group to assist it in considering strategic alternative, but he indicated that strategic changes such as a sale or spin off need to happen soon. He added that if no sale of a division or the whole company is forthcoming, Brinks should begin “aggressively” buying back shares, hiking its current repurchase program from $100 million to $500 million

“To the extent it is determined, based on advice from Monitor Group or otherwise, that Brinks will not pursue a tax free spin-off or other strategic alternative, we demand that Brinks pursue an immediate sale of the company in a process that maximizes value for all shareholders,” Lichtenstein wrote.

Meanwhile, MMI’s efforts are on-going. On Dec. 12, the group indicated they were supportive of the Monitor Group addition, but no indication was made to end the proxy contest.

“We believe the director slate we’ve nominated is well qualified, with a breadth and depth of business experience to maximize value for all Brinks stockholders,” Lifflander wrote in November. “We are not seeking control of the board. We simply believe that the board as currently composed has demonstrated that it lacks the security industry perspective, strategic alternatives acumen and stockholder representation necessary to protect and maximize the value of Brink’s stockholders’ investment.”

Lifflander said in his letter that he believes the armored car company lacks industry experience on its board. He is seeking to nominate John Dyson, the chairman of MCM Capital Management; Peter Michel, former chief executive of Brink's residential security monitoring unit; Robert Strang, the CEO of Investigative Management Group; and Exide Technologies director Carroll Wetzel. “Our nominees fill major gaps in the experience and skill set of the current directors, particularly as the board has limited direct Wall Street experience and no expertise in the security industry, other than chairman, CEO & president Michael Dan,” he added.

MMI Investments has been engaging Brink’s since 2003 and has lately pushed for a sale of the company. In 2005 the hedge fund began publicly agitating for Brink’s to sell its marginally profitable BAX Global subsidiary, an international heavy freight and logistics operator, which was subsequently sold for roughly $1.1 billion. - Ron Orol

Tuesday, January 8, 2008

More activists were circling prey in 2007

Activist investing gained steam in 2007. At least that's the conclusion reached by new data produced by FactSet Research System's SharkWatch product.
The research company reported that activist campaigns went up 17% in 2007, rising to 501 from 429 in 2006. Additionally, 138 institutional investors and other investors launched their first ever campaigns in 2007.
John Laide, product manager of FactSet SharkWatch, says that the activist campaigns considered in the study relate to any agitation for change, including proxy fights and efforts to have corporations sell divisions, complete stock buybacks or issue special dividends, among many other tactics.
Some less high-profile activist efforts are included as well. Laide added that when activist hedge funds report in government filings that they have had discussions with management about potential ideas to improve shareholder value, that effort is often included as an activist campaign.
SharkWatch tracks activist Securities and Exchange Commission filings such as Schedule 13Ds. - Ron Orol
See SharkWatch Report
Ron Orol is a Washington-based reporter for The Deal and author of Extreme Value Hedging: How Activist Hedge Fund Managers Are Taking on the World.

Monday, January 7, 2008

Costa Brava seeks answers from MedQuist

Activist investor Costa Brava Partnership III LP sent a missive to Medquist Inc. director Clement Revetti Jr. on Monday, arguing that board members have serious conflicts related to the sale of the medical billing company. The Costa Brava letter comes after Royal Philips Electronics NV on Nov. 2 said it would sell its 70% stake in MedQuist. On July 6, the Netherlands consumer electronics giant announced the Mount Laurel, N.J.-based unit was a noncore asset.
According to a regulatory filing on Monday, Costa Brava sent a letter to Revetti expressing concerns about the replacement of three independent MedQuist directors, arguing that the replacement of these individuals is a "violation of the governance agreement" that governs the relationship between Philips and MedQuist.
"The process by which Philips and its functionaries are forcing the sale of the entirety of MedQuist is illegitimate, as it is being directed by a conflicted and incomplete board," Costa Brava senior vice president Andrew Siegel said in the letter.
It comes after Costa Brava in November sought to inspect the medical billing company's shareholder list, books and other records for the past seven years. "Accordingly, this letter shall serve as a formal request on behalf of Costa Brava to inspect and copy the company's list of all shareholders and the books and records of accounts and minutes of all proceedings of shareholders, board and executive committees from January of 2000 until the present," the November letter stated. "We demand that such an inspection take place on or before Friday, Nov. 9."
MedQuist's troubles began in late 2003 when a whistleblower charged it engaged in improper billing. It was delisted from Nasdaq in June 2004 after failing to meet reporting requirements. MedQuist has hired Bear, Stearns & Co. to advise it on strategic alternatives.
Costa Brava reported having a 5.2% stake in the billing company. MedQuist, which has a $381 million stock market capitalization, provides medical transcription technology and services in the U.S. It also offers digital dictation, speech recognition, electronic signature, and medical coding technology and services. - Ron Orol
See schedule 13D filing from SEC EdgarSee TheDeal.com: MedQuist recruits Bear StearnsSee TheDeal.com: Philips bids high to buy 60% of MedQuist
Ron Orol is a Washington-based reporter for The Deal and author of Extreme Value Hedging: How Activist Hedge Fund Managers Are Taking on the World.

Friday, January 4, 2008

RLR Capital Expands Effort at 1-800 Flowers.Com

The flowers may soon bloom at 1-800 Flowers.Com, at least that’s what it looks like to an activist investor that hiked his stake in the company on Friday.

Robert L. Rosen and RLR Capital Partners LP raised their stake in the Carle Place, NY-based fresh-cut flowers retailer to 6.3% from 5.1%. The activist first reported an original Schedule 13D Securities and Exchange Commission filing on June 27. In it, RLR Capital Partners said the flower retailer’s shares were “substantially” undervalued and that the hedge fund’s managers “have had, and expect to continue to have, discussions” with the company’s management about business prospects. In a letter to 1-800 Flowers.Com executives on June 27, Rosen expressed support for the company’s strategy but also indicated that the company should “pursue” opportunities to “enhance” shareholder value.

“As your free cash flow builds over the coming months and years, you will have capital structure and allocation opportunities. We remain confident that you will continue to pursue those opportunities which will most greatly enhance shareholder value,” he wrote.

1-800 Flowers.Com has a $454 million stock market capitalization. -- Ron Orol

Thursday, January 3, 2008

Activist Expands Zale effort

Securities and Exchange Commission chairman turned activist hedge fund manager didn’t get the Christmas gift he was looking for at Zale Corp. this December. Now he’s hoping Santa will make a rain-check visit in January.

Breeden, founder of mid-capitalization activist hedge fund Breeden Capital Management LLC, on Wednesday hiked his stake in Zale Corp. to 15.1% from 7.7% on Jan. 2 as part of his effort nudge the specialty jewelery retailer into considering strategic options such as auctioning off key assets.

Breeden launched a public activist effort in September, when he filed a Securities and Exchange Commission Schedule 13D detailing that he met with the Irving, Texas-based corporation’s management. In the filing, Breeden said he plans to continue discussions with executives and directors. Talks between Breeden and Zale centered on the company’s financial performance and strategic options for the jewelry company such as an auction of key assets.

Breeden’s effort also comes after Zale in December replaced CEO Mary E. “Betsey” Borton with Neal Goldberg, who will also be president.

In the spring Zale reported that it had hired investment bankers to review strategic alternatives such as selling some assets including its Bailey Banks & Biddle brand and Piercing Pagoda mail kiosks brand. In June 2006, Zale reported it had held unproductive talks to be acquired by mega-jewelry retailer Signet Group plc of London, U.K. (Signet operates the Kay and Jared jewelry chains). In a recent conference call with analysts on Aug. 30, then-Zale Chief Executive Betsy Burton said she has analyzed the viability of selling some of its assets, but she declined to elaborate. But at a Goldman Sachs retail conference on Sept. 6, Burton said Zale will consider closing some unproductive stores and divesting some brands, though no sales were imminent.

Wednesday, January 2, 2008

Activists ask Syms to closet delisting plan

Two activist investors on Wednesday launched a campaign to stop Syms Corp., a New York discount clothing retailer, to reconsider its decision to delist from the New York Stock Exchange.
Barington Capital Group and Esopus Creek Advisors, who together own 9.7% of Syms, sent a letter to Syms' board expressing their displeasure with the company's decision to deregister. "The group believes that such actions will destroy shareholder value," Barington and Esopus Creek wrote in the letter that was attached to a Schedule 13D filing with the Securities and Exchange Commission.
In its statement, Syms argues that investors will be able to buy and sell stock on the pink sheets, maintaining a sufficient level of liquidity and the deregistration will save the company $750,000. "The company estimates that the savings in both direct and indirect costs associated with deregistration will be substantial on an ongoing basis and that the direct recurring annual savings will exceed $750,000," Syms wrote in a Dec. 21 press release. "The company also expects that management will be able to better focus its attention and resources on continuing to improve operations and enhancing shareholder value."
But investors following the company contend that the real reason why Syms wants to deregister is to lower the value of the stock price so that management, including store founder Sy Sims, 81, could complete a management-led buyout at an inexpensive valuation leaving shareholders with lost value.
"It appears that the Syms family does not believe that their company's motto 'An educated consumer is our best customer' should apply to its investors as well," stated a large investor that requested anonymity. - Ron Orol
See Schedule 13D filing via the SEC's Edgar See press release via Yahoo! Finance
Ron Orol is a Washington-based reporter for The Deal and author of Extreme Value Hedging: How Activist Hedge Fund Managers Are Taking on the World.

Advisory firm supports Ramius' Luby campaign

The battle for the future of Luby's Inc. intensified Wednesday after shareholder advisory group Proxy Governance Inc. recommended that investors vote to support three of four dissident director candidates nominated by activist hedge fund Ramius Capital Group LLC for the cafeteria operator's 10-person board.
The activist investor group launched a proxy contest on Oct. 17 to nominate four director candidates to Luby's board at the company's annual meeting scheduled for Jan. 15. Proxy Governance also recommended to shareholders that they vote to support an investor proposal seeking to remove Luby's anti-takeover protection, classified board structure.
Luby's, an operator of 130 cafeteria-style restaurants in Texas, on Oct. 31 launched its own campaign, hoping to maintain control of the company's destiny and the support of its institutional investor base.
The restaurant chain on Wednesday issued a proxy to investors lashing out at Ramius' nominees, criticizing them for their limited experience in the restaurant industry or how their background has "little relevance to Luby's from-scratch cooking and casual dining." One nominee, Luby's wrote, is a Ramius director "for hire," has no restaurant industry experience and was recently rejected by shareholders of another publicly traded company.
The activists have taken issue with the company's granting Christopher Pappas, Luby's president, and Harris Pappas, his brother, an exemption from Luby's poison pill, allowing them to own up to 28% of the company's shares, instead of the 15% allowed for other shareholders. While the Pappas brothers argue that increasing their personal financial stake in the company demonstrates their commitment to making sure the company's share price improves, Ramius is concerned that the greater ownership will mean more votes for management-backed directors (and less for them) at the contentious meeting. Ramius has also criticized how, in addition to Luby's, the Pappas brothers operate a private business, which means they have less time to focus on the publicly held Luby's. - Ron Orol